Bryan Haines1, James Hughes, Mark Corbett, Marie Shaw, Josie Innes, Leena Patel, Jozef Gecz, Jill Clayton-Smith, Paul Thomas. 1. School of Molecular & Biomedical Science (B.H., J.H., P.T.), Robinson Research Institute (B.H., J.H., M.C., M.S., J.G., P.T.), School of Pediatrics and Reproductive Health (M.C., M.S., J.G.), The University of Adelaide, Adelaide, Australia 5005; Manchester Centre For Genomic Medicine (J.I., J.C.-S.), Central Manchester National Health Service Foundation Trust, University of Manchester, Manchester M13 9WL; and Department of Child Health (L.P.), Royal Manchester Children's Hospital, University of Manchester, Manchester M13 9WL.
Abstract
CONTEXT: 46,XX male sex reversal occurs in approximately 1: 20 000 live births and is most commonly caused by interchromosomal translocations of the Y-linked sex-determining gene, SRY. Rearrangements of the closely related SOX3 gene on the X chromosome are also associated with 46,XX male sex reversal. It has been hypothesized that sex reversal in the latter is caused by ectopic expression of SOX3 in the developing urogenital ridge where it triggers male development by acting as an analog of SRY. However, altered regulation of SOX3 in individuals with XX male sex reversal has not been demonstrated. PATIENTS AND METHODS: Here we report a boy with SRY-negative XX male sex reversal who was diagnosed at birth with a small phallus, mixed gonads, and borderline-normal T. Molecular characterization of the affected individual was performed using array comparative genomic hybridization, fluorescent in situ hybridization of metaphase chromosomes, whole-genome sequencing, and RT-PCR expression analysis of lymphoblast cell lines. RESULTS: The affected male carries ∼774-kb insertion translocation from chromosome 1 into a human-specific palindromic sequence 82 kb distal to SOX3. Importantly, robust SOX3 expression was identified in cells derived from the affected individual but not from control XX or XY cells, indicating that the translocation has a direct effect on SOX3 regulation. CONCLUSION: This is the first demonstration of altered SOX3 expression in an individual with XX male sex reversal and suggests that SOX3 can substitute for SRY to initiate male development in humans.
CONTEXT: 46,XX male sex reversal occurs in approximately 1: 20 000 live births and is most commonly caused by interchromosomal translocations of the Y-linked sex-determining gene, SRY. Rearrangements of the closely related SOX3 gene on the X chromosome are also associated with 46,XX male sex reversal. It has been hypothesized that sex reversal in the latter is caused by ectopic expression of SOX3 in the developing urogenital ridge where it triggers male development by acting as an analog of SRY. However, altered regulation of SOX3 in individuals with XX male sex reversal has not been demonstrated. PATIENTS AND METHODS: Here we report a boy with SRY-negative XX male sex reversal who was diagnosed at birth with a small phallus, mixed gonads, and borderline-normal T. Molecular characterization of the affected individual was performed using array comparative genomic hybridization, fluorescent in situ hybridization of metaphase chromosomes, whole-genome sequencing, and RT-PCR expression analysis of lymphoblast cell lines. RESULTS: The affected male carries ∼774-kb insertion translocation from chromosome 1 into a human-specific palindromic sequence 82 kb distal to SOX3. Importantly, robust SOX3 expression was identified in cells derived from the affected individual but not from control XX or XY cells, indicating that the translocation has a direct effect on SOX3 regulation. CONCLUSION: This is the first demonstration of altered SOX3 expression in an individual with XX male sex reversal and suggests that SOX3 can substitute for SRY to initiate male development in humans.
Authors: Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper Journal: Endocr Rev Date: 2016-11-09 Impact factor: 19.871
Authors: Felix Boschann; Daniel Acero Moreno; Martin A Mensah; Henrike L Sczakiel; Karolina Skipalova; Manuel Holtgrewe; Stefan Mundlos; Björn Fischer-Zirnsak Journal: J Hum Genet Date: 2022-01-31 Impact factor: 3.755
Authors: Megan H Brewer; Rabia Chaudhry; Jessica Qi; Aditi Kidambi; Alexander P Drew; Manoj P Menezes; Monique M Ryan; Michelle A Farrar; David Mowat; Gopinath M Subramanian; Helen K Young; Stephan Zuchner; Stephen W Reddel; Garth A Nicholson; Marina L Kennerson Journal: PLoS Genet Date: 2016-07-20 Impact factor: 5.917
Authors: Sjors Middelkamp; Judith M Vlaar; Jacques Giltay; Jerome Korzelius; Nicolle Besselink; Sander Boymans; Roel Janssen; Lisanne de la Fonteijne; Ellen van Binsbergen; Markus J van Roosmalen; Ron Hochstenbach; Daniela Giachino; Michael E Talkowski; Wigard P Kloosterman; Edwin Cuppen Journal: Genome Med Date: 2019-12-04 Impact factor: 11.117
Authors: Mary García-Acero; Olga Moreno-Niño; Fernando Suárez-Obando; Mónica Molina; María Carolina Manotas; Juan Carlos Prieto; Catalina Forero; Camila Céspedes; Jaime Pérez; Nicolas Fernandez; Adriana Rojas Journal: Mol Med Rep Date: 2019-11-12 Impact factor: 2.952